Abstract Policy makers and health care payers are concerned about the costs of treating terminal patients. This study was done to measure the costs of treating terminal patients during the final month of life in a sample of Belgian nursing homes from the health care payer perspective. Also, this study compares the costs of palliative care with those of usual care. This multicenter, retrospective cohort study enrolled terminal patients from a representative sample of nursing homes. Health care costs included fixed nursing home costs, medical fees, pharmacy charges, other charges, and eventual hospitalization costs. Data sources consisted of accountancy and invoice data. The analysis calculated costs per patient during the final month of life at 2007/2008 prices. Nineteen nursing homes participated in the study, generating a total of 181 patients. Total mean nursing home costs amounted to 3,243 € per patient during the final month of life. Total mean nursing home costs per patient of 3,822 € for patients receiving usual care were higher than costs of 2,456 € for patients receiving palliative care (p = 0.068). Higher costs of usual care were driven by higher hospitalization costs (p \ 0.001). This study suggests that palliative care models in nursing homes need to be supported because such care models appear to be less expensive than usual care and because such care models are likely to better reflect the needs of terminal patients.
Introduction
In an era of spiraling health care costs and limited resources, policy makers and health care payers are concerned about the costs of treating terminal patients. To date, there is only scarce research about such costs. A recent article reviewed the international literature and found that hospitalization costs represent the principal component of the costs of treating terminal patients across health care settings [1] . Although a few US articles have been published about the costs of treating terminal patients in nursing homes [2, 3] , no European study has been conducted in this domain to the best of the authors' knowledge.
In Belgium, the Independent Sickness Funds estimated that expenditure on palliative care increased from 42 million € in 2003 to 77 million € in 2007, an annual average increase of 16% [4] . Palliative care accounted for 0.4% of Belgian health expenditure in 2007. Breaking down the costs of ambulatory palliative care for terminal patients, a study found that expenditure could be attributed to home nursing (61% of expenditure), mobile palliative support teams (13%), the palliative home care allowance (12%), nursing homes (11%), and the abolition of the patient copayment for consultation by the general practitioner (3%) in Belgium in 2003 [5] . The aim of this study was to measure the costs of treating terminal patients during the final month of life in a sample of Belgian nursing homes from the health care payer perspective and comparing the costs of treating terminal patients with palliative care or usual care. This study was undertaken as part of a larger study on palliative care in Belgium commissioned by the Belgian Healthcare Knowledge Centre [6] . This cost analysis contributes to the literature by comparing different types of care for patients with a similar profile, i.e., at the end of life, independently of the underlying pathology. Furthermore, cost estimates can provide insight into the economic burden of caring for terminal patients when considered alongside evidence of morbidity and mortality. Finally, cost data can be fed into economic evaluations so that decision makers can ascertain the cost-effectiveness of various nursing home care models for terminal patients by examining their effectiveness in relation to their costs.
Methods
This retrospective, multicenter cohort study compared the costs of palliative care or usual care for terminal patients in Belgian nursing homes. This study was approved by the Ethical Committee of the University Hospitals Leuven.
Selection of institutions
Belgium has public and Catholic nursing homes that are located in either the Dutch-speaking or the French-speaking part of the country. As costs may vary based on these characteristics, the study included a representative sample of public and Catholic nursing homes in Dutch-speaking and French-speaking Belgium. Specific nursing homes satisfying these criteria were selected for pragmatic reasons (e.g., intention to collaborate in the study).
Selection of patients
The study enrolled nursing home residents who died between 1 July 2007 and 31 December 2007. The starting date was intentionally chosen because invoicing procedures for Belgian nursing homes became legally more transparent from that date onward. Patients who moved to another nursing home or were admitted to the nursing home during the 30 days preceding death were excluded.
As the type of pathology influences costs, the study was restricted to terminal patients who suffered from a chronic disease. This means that acute illness, sudden death, and death due to therapeutic complications were excluded. Two researchers, a physician and a nurse, assessed the real care provided to terminal patients with a view to determining whether the patient received palliative or usual care. This assessment was carried out in collaboration with the treating physician and/or nurse. All files of eligible patients were analyzed by the researchers to examine the decisionmaking process at the end of life. Exclusion criterion was incomplete medical/nursing records. The following decision algorithm was used by the two researchers to label terminal patients as receiving palliative or usual care (Fig. 1) . First, there was a meeting between the researchers and the chief nurse and/or the treating physician(s) or the palliative nurse to clarify the institutional attitudes concerning the transition from cure to care. The following points were discussed, e.g., availability of written palliative guidelines, use of 'do not reanimate codes, practice of advanced care planning in palliative care, and management of terminal patients.
Then, the researchers analyzed, among other things, diagnosis, seriousness, and stage of the disease; administration of drugs, artificial food, and fluid; diagnostic and therapeutic interventions to verify whether patients effectively received either palliative care or usual care. On the one hand, if a usual care patient in practice only received pain and symptom control, the patient was registered in the palliative care group. On the other hand, some palliative care patients received diagnostic or therapeutic interventions, sometimes started by the physician in charge, sometimes on request of the family. In this case, the patient was included in the usual care group based on actual practice rather than intent-to-treat practice. Patients could also follow a mixed care model: patients may originally be classified as receiving usual care and then switch to palliative care. In this case, patients were assigned to a group based on their actual care and the principles described above.
Sample size
To the best of the authors' knowledge, this is the first study of the costs of treating terminal patients in Belgian nursing homes. In the absence of data on the prevalence of terminal patients and on the variance of costs at the time of the study, it was not possible to use statistical formulae to calculate sample sizes or explore specific hypotheses (e.g., cost differences between nursing homes) using statistical tests. Instead, this cost analysis carried out a descriptive study quantifying costs. The results may serve to inform sample size calculations for future studies. The study intended to enroll 50 patients at random from each type of nursing home. The overall target was set at 200 patients.
Time horizon
The time horizon of the cost analysis was 30 days preceding patient death. This time horizon is also in line with previous cost studies of terminal patients [7] [8] [9] [10] . However, it was not always possible to attribute costs to the final month of life when invoices did not state the date on which the health care cost was incurred. This is, for example, the case for specific incontinence materials and medication. Such costs were proportionally allocated to correspond to the time horizon of 30 days preceding the death of the patient. This study was carried out between January 2008 and May 2009.
Data sources
The analysis took the health care payer perspective. In line with pharmacoeconomic guidelines in Belgium [11] , payer perspective includes health care costs incurred by the Belgian third-party payer, the National Institute for Health and Disability Insurance (NIHDI) and costs incurred by patients (i.e., patient copayments). These costs comprised invoices by nursing homes to patients (e.g., medical fees, pharmacy) and fixed nursing home costs (paid by patients in the form of a daily tariff). Eventual hospitalization costs during the 30 days preceding death were included. Real costs were quantified based on actual resource use wherever possible. In general, actual resource use with respect to fixed costs of nursing homes was computed. This means that a detailed exercise extracted relevant cost information from accounting data in each participating nursing home instead of using charges for hotel services. The measurement of costs provides a major added value to this analysis. Moreover, charge data were used for some items for practical reasons. Data sources are, therefore, based on a mixture of cost and charge data. Such an approach has been adopted by previous studies on the costs of terminal patient care [12] . Fixed costs of nursing homes were based on actual resource use as derived from the accounting system and related to nursing staff, energy (i.e., heating, water, and electricity), pharmacy (i.e., medicines and medical devices), technical devices (e.g., toilet chair, crutches), and nourishment. Invoices provided data on charges related to medical fees (for outpatient physician consultations), pharmacy (i.e., medicines and medical devices), and other charges (i.e., additional nourishment, telephone, hairdresser, transportation for ambulatory care, ambulatory care). Costs of washing bed linen were not included, as it was not possible to extract data on the additional washing costs attributable to the care of a terminal patient. Eventual hospitalization costs during the 30 days preceding death included fixed hospital costs, charges incurred by the NI-HDI, and charges incurred by the patient. These data were taken from a previous study [13] and related to a representative sample of Belgian hospitals, i.e., a university hospital, a public hospital, and a Catholic hospital-one of each type in Dutch-speaking and French-speaking Belgium. Fixed hospital cost data originated from the Belgian hospital FINHOSTA accounting system [14] , thereby guaranteeing consistency and data comparability between hospitals. These accounting data served to calculate costs of hospital staff (excluding medical fees), energy (i.e., heating, water, and electricity), infrastructure, and nourishment. Invoice data reflected charges relating to medical fees (for physician consultations, laboratory tests, clinical biology), pharmacy (medicines and medical devices), and other charges (i.e., telephone costs and additional costs for a single room).
Data analysis
The analysis calculated costs per patient during the final month of life. Estimates of fixed nursing home costs related to the full year of 2007. In order to generate a cost per patient per day, annual fixed nursing home costs were divided by the number of lay days (i.e., days that patients occupy a bed). The number of lay days includes the time that a patient spent in hospital because the nursing home continues to incur fixed costs during that time period. Fixed costs per patient were added to medical fees, pharmacy charges, and other charges to obtain a total cost per patient during a patient's stay in a nursing home. The mean hospital costs per patient per day were multiplied by the number of days that a patient stayed in hospital. Nursing home and hospital costs were added to attain a total cost per patient during the final month of life. No uniform accounting system exists for nursing homes in Belgium. Therefore, the analysis of fixed costs relied on accounting data that differ between participating nursing homes. This may be a source for variability in estimates of total patient costs between nursing homes. To minimize this effect, mean fixed costs per patient per day were calculated across all participating nursing homes, and this mean cost was then applied to compute costs for each individual terminal patient staying in a nursing home, i.e., mean fixed costs per patient per day were multiplied by the number of days that a patient stayed in a nursing home. Cost estimates were broken down in terms of nursing home fixed costs, pharmacy charges, medical fees, other charges and hospital costs. Costs were calculated at 2007/2008 prices. Costs of terminal patients who receive palliative care or usual care were compared using the Mann-Whitney U test for variables not having a normal distribution.
Results
Patients were initially selected from one institution per type of nursing home (i.e., public/Catholic nursing homes in Dutch-speaking and French-speaking Belgium). However, due to the limited number of terminal patients receiving palliative or usual care in each institution, multiple institutions had to be enrolled for some types of nursing homes. In total, 39 nursing homes were contacted, 19 of which consented to participate in this study. The sample included 50 patients from Dutch-speaking public nursing homes, 49 patients from Dutch-speaking Catholic nursing homes, and 50 patients from French-speaking Catholic nursing homes. As the number of patients that could be enrolled from public nursing homes in French-speaking Belgium was limited, it was not possible to extract a random sample: all 32 eligible patients were included. A total of 181 patients were included in the sample. Mean fixed nursing home costs per patient per day amounted to 49.6 €. This cost consisted of nursing staff 38.6 €, energy 2.3 €, pharmacy 1.0 €, technical devices 0.4 €, and nourishment 7.3 €. During the 30 days preceding death, patients stayed on average 25 days in a nursing home and 5 days in hospital. Mean hospital costs per patient per day amounted to 391 €. Table 1 gives an overview of mean costs per patient per day across nursing homes and for each nursing home separately. Total mean nursing home costs amounted to 3,243 € per patient over the final month of life. This corresponds with 108 € per patient per day. When hospital costs were excluded, total mean nursing home costs amounted to 57 € per patient per day. There was substantial variation in total nursing home costs per patient per day between institutions and between patients within institutions. The major drivers of total mean nursing home costs of 3,243 € per patient were hospital costs (mean 1,787 €; 55% of total mean nursing home costs per patient) and fixed nursing home costs (1,256 €; 39%). Costs of pharmacy, medical fees, and other charges made up 6% of nursing home costs per patient during the final month of life.
The sample of 181 terminal patients consisted of 108 receiving usual care and 56 receiving palliative care. Seventeen patients followed a mixed care program: they originally received usual care and then switched to palliative care. Based on the criteria described above, four patients were assigned to the usual care group and 13 patients to the palliative care group. Are there any cost differences between nursing home patients receiving palliative care and those receiving usual care? Table 2 shows that total mean nursing home costs per patient during the final month of life of 3,822 € for patients receiving usual care tended to be higher than costs of 2,456 € for patients receiving palliative care (p = 0.068). Higher costs of usual care were driven by higher hospitalization costs (p \ 0.001). Higher hospitalization costs were attributed to a longer length of stay in hospital of nursing home patients receiving usual care. However, fixed nursing home costs (p = 0.009), pharmacy costs (p = 0.002), and medical fees (p \ 0.001) were significantly lower for patients receiving usual care. No difference was observed between palliative care and usual care in terms of other charges.
Discussion
This study measured the costs of treating terminal patients during the final month of life in Belgian nursing homes. It also found that the costs of usual care exceeded the costs of palliative care, a result of a longer length of stay in hospital. The researchers faced problems given the complexity Results are presented as mean ± standard deviation of relevant resources for terminal patients in Belgian nursing homes. Therefore, during this investigation, particular attention was paid to all costs necessary to achieve a truthful and complete representation of the costs of treating terminal patients. An extensive cost model was set up drawing on data from a variety of sources. This is an optimal approach in the absence of publicly available data, but the reader should note that the findings give an approximation of the costs but do not represent exact cost data.
An innovative feature of this study is the detailed data collection of real costs in institutions based on actual resource use wherever possible. The consequence of this methodological choice is that the research team invested a considerable amount of time and effort in enrolling institutions and patients. The research team still succeeded in including 19 nursing homes and 181 patients in the sample. Recruitment also involved the need to obtain approvals of nursing home management and individual physicians caring for terminal patients.
To date, little is known about treating terminal patients in terms of the level of costs, the distribution of costs between health care settings, and the cost drivers of treating terminal patients. Our study is one of the few analyses eliciting the costs of treating terminal patients in nursing homes. Our results are in line with the findings of a review of the international literature on such costs [1] . This review showed that hospitalization costs represent the principal component of the costs of treating terminal patients and that palliative care is cheaper than usual care, with the latter effect being investigated and demonstrated when treating terminal patients across health care settings and in the hospital setting.
This research has a number of limitations. Data were collected retrospectively. For pragmatic reasons, it was not feasible to select prospectively a sufficient number of terminal patients receiving palliative or usual care in all participating nursing homes, follow all patients until their death, and wait for another couple of months before the nursing home invoices and hospital bills are issued. The choice for a retrospective rather than prospective study design is not expected to influence cost estimates given that these estimates were based on accounting data and charges. The comparison of costs between palliative care and usual care needs to be interpreted with caution. As a randomized controlled trial raises ethical concerns, our study adopted a cohort design. The internal validity of the cost comparison of care programs may be undermined by the small patient sample, may be subject to selection bias because patients (or the family on behalf of patients) self-selected their care program, and may be subject to performance bias because care programs are not substitutes for each other and may vary between individual nursing homes. Although patients receiving palliative care and patients receiving usual care were comparable with regard to chronic diseases, we did not collect data on other demographic, clinical, and socioeconomic characteristics to explore whether such patient characteristics explained cost differences between palliative and usual care. Although these possible forms of bias may affect the size of our cost estimates, they are unlikely to change the conclusion that palliative care models in nursing homes tend to be less expensive given that the observed cost differences between palliative care and usual care were large. Also, our cost estimates possess external validity in that they reflect differences in patient profiles and care programs as observed in real practice. The institutions to which patients belonged differed between patients receiving palliative and usual care. This choice was made in order to enroll a sufficient number of patients in the study. However, this means that cost differences between palliative and usual care may not only reflect differences in care programs but also cost variation between institutions. It is not clear how possible cost differences between institutions would affect the cost estimates of patients receiving palliative or usual care. This analysis purported to compute the cost difference between palliative and usual care. However, this was not possible when calculating fixed nursing home costs. Annual fixed costs reflected the mix of patients receiving palliative and usual care in each institution. Annual costs were then converted into a fixed cost per day per patient, irrespective of whether a patient received palliative or usual care. It follows that observed cost differences between palliative and usual care do not derive from differences in fixed costs per day per patient but from other factors, such as differences in length of hospital or nursing home stay, medical fees, or pharmacy costs. Costs in nursing homes may be influenced by the size of the institution, as measured, for instance, by the number of beds. This factor was not taken into account in our sample because few large nursing homes were willing to participate and because the number of patients that could be enrolled from small nursing homes was limited. Also, an expert panel convened by the Belgian Healthcare Knowledge Centre believed that the size of the institution was not a relevant factor and, thus, is unlikely to affect our cost estimates.
The reader must be careful when assessing the generalizability of our cost estimates to other health care settings or other countries for a number of reasons. First, the organization and financing of health care systems vary between countries, implying that therapeutic services, their availability, and associated costs differ. Second, different approaches can be used to define the terminal status of a patient: (a) by the patient readiness, i.e., the patient is ready to address terminal issues when he/she is aware of his/her prognosis; (b) by the severity of illness: Is this patient sick enough that it would not be a surprise if he or she would die within 6 months (or 3 or 12 months)?; and (c) by the prognosis expressed by the physician as the risk of dying [15] . Third, the definition, nature, and content of palliative and usual care vary between health care settings and countries.
Further research needs to be undertaken to refine and validate our estimated costs of treating terminal patients in Belgian nursing homes. Such an exercise would benefit from a uniform accounting system for nursing homes in Belgium. Also, studies need to calculate costs of treating terminal patients in other settings, including in hospital and at home. Such research may aid policy makers in developing reimbursement mechanisms that closer reflect real costs.
